[1] PubMed ID: | 35734878 |
Disease Name: | Diabetic Retinopathy |
Sample: | patients with diabetic retinopathy |
Dysfunction Pattern: | Regulation( TGF-β signaling) |
Validated Method: | Western Blot//Transfection//qRT-PCR//Cell Apoptosis Assay//Cell Proliferation Assay |
Description: | We found that ZNF503-AS1 was not differentially expressed in healthy participants and diabetic patients. Plasma lncRNA ZNF503-AS1 level was higher in patients with diabetic retinopathy than in patients with other complications (p < 0.05). We concluded that ZNF503-AS1 might participate in diabetic retinopathy by activating TGF-β signaling. |
Causality: | Yes |
Causal Description: | ZNF503-AS1 overexpression inhibited proliferation, promoted cell apoptosis, and upregulated TGF-β1 expression (p < 0.05). |
Clinical-realted Application: | High plasma lncRNA ZNF503-AS1 level was correlated with a high incidence of diabetic retinopathy. |